Better Cannabis Stock: Cronos Group vs. Tilray
There hasn't been much good news for either Cronos Group (NASDAQ: CRON) or Tilray (NASDAQ: TLRY) so far this year. Both companies hoped that the Canadian cannabis retail environment would improve in 2020, but then the COVID-19 pandemic hit.
Tilray has been by far the bigger loser year to date, with its shares down nearly 60% -- more than twice the size of the decline in Cronos stock. Which of these Canadian cannabis stocks is the better pick looking ahead? Here's how Cronos and Tilray compare.
Image source: Getty Images.
Source Fool.com
